Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs
NCT06112470 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2023-11-01
Summary
This study focuses on the experience of the military patient reporting a suspected drug allergy, with its own specificities. Suspicions of drug allergies during a mission expose the doctor to difficulties.
This study will improve understanding of the allergy patient's point of view. The end result could be a set of ideas for measures to raise awareness among these patients, and motivate them to undergo an allergological assessment.
Conditions
- Allergy Penicillin
Interventions
- OTHER
-
Interview
Semi-structured interview on experiences, perceptions, beliefs and knowledge of drug allergy and barriers to allergological testing, with a view to content analysis.
Sponsors & Collaborators
-
Direction Centrale du Service de Santé des Armées
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-02-28
- Primary Completion
- 2024-02-29
- Completion
- 2024-03-31
Countries
- France
Study Locations
More Related Trials
-
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
NCT02041624 ·Status: TERMINATED
-
Allergic Versus Non Allergic Hypersensitivity Drug Reaction (BdDAllergo)
NCT03369509 ·Status: TERMINATED
-
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
NCT00813748 ·Status: COMPLETED
-
A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge
NCT00562120 ·Status: COMPLETED ·Phase: PHASE2
-
Special Drug Use Investigation for ALLERMIST (Long Term)
NCT01420822 ·Status: COMPLETED
-
Quality of Life of Patients With a History of Drug Allergy in Thailand
NCT01666470 ·Status: COMPLETED
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination
NCT05009134 ·Status: UNKNOWN
-
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
NCT02320396 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)
NCT00779545 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
NCT01160861 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen
NCT05126316 ·Status: COMPLETED ·Phase: PHASE1
-
Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers
NCT05381207 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Nasal Allergen Challenge in Rhinitic Subjects
NCT01286129 ·Status: COMPLETED ·Phase: NA
-
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges
NCT07038746 ·Status: RECRUITING ·Phase: PHASE1
-
Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)
NCT00405964 ·Status: COMPLETED ·Phase: PHASE3
-
A Training Program of Drug Allergy for Healthcare Professionals
NCT06399601 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
NCT05210543 ·Status: RECRUITING
-
Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 ·Status: COMPLETED
-
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
NCT00599872 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)
NCT00468312 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges
NCT06445374 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Use Investigation for ALLERMIST
NCT01376206 ·Status: COMPLETED
-
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
NCT00978029 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen
NCT00519740 ·Status: COMPLETED ·Phase: NA